Clinical Trials Logo

Filter by:
NCT ID: NCT02594540 Completed - Parkinson's Disease Clinical Trials

Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation

Start date: December 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate safety and effectiveness of the peripheral mechanical stimulation of the feet on gait variables, clinical status, risk of falls, BDNF levels, immunological profile and brain functional connectivity changes in patients with Parkinson's disease.

NCT ID: NCT02594514 Completed - Obesity Clinical Trials

Laparoscopic Sleeve Gastrectomy in Severely Obese Adolescents: Effects on Metabolism

Start date: January 2007
Phase: N/A
Study type: Observational

Severe obesity (SO), defined as BMI≥95th percentile, has increased worldwide among adolescents. American studies estimated that 1.3-2.8% of 12-19-year-old individuals have a BMI >40 kg/m2 or a BMI >35 kg/m2 with at least one serious co-morbidity. The immediate and long-term risks associated with SO in adolescents include cardiovascular and metabolic diseases, obstructive sleep apnoea and nonalcoholic fatty liver disease. However, the results of sleeve gastrectomy in adolescents are still uncertain. Objective and hypotheses: Investigators aimed to assess the long-term safety, efficacy, and cardiovascular risk changes of laparoscopic sleeve gastrectomy in adolescents with SO. Method: Longitudinal retrospective study of 22 adolescents with SO who underwent laparoscopic sleeve gastrectomy. Clinical and metabolic variables immediately before surgery and after 6, 12, 18 and 24 months were assessed.

NCT ID: NCT02594462 Completed - Sickle Cell Disease Clinical Trials

Contraception in Women With Sickle Cell Disease

Start date: January 2015
Phase: Phase 4
Study type: Interventional

Sickle cell anemia is a homozygous genetic disease with high prevalence in Brazil. There are changes in conformation and physicochemical properties of red cells that generate varied clinical manifestations among which is chronic hemolytic anemia, cardiovascular diseases, fever, splenic sequestration and usually painful crises. Women with sickle cell anemia have high maternal-fetal and neonatal morbidity and mortality. During pregnancy, there is intensification of maternal anemia, episodes of painful crises; and also, more obstetric risks, such as pre-eclampsia, thromboembolism and hemorrhage. Thus, there is the need for adequate reproductive family planning for this population conducted mainly through hormonal contraception. The World Health Organization recommends that all contraceptive methods may be prescribed for people with sickle cell anemia women, being the progestogen-only contraceptive methods the most indicated due to no changes in venous or arterial thrombosis. Nevertheless, there is need for further scientific evidence as the best contraceptive choice among women with sickle cell anemia in relation to safety, adhesion and reduction of pain crises. The objective of this study is to evaluate the clinical effect through safety of etonogestrel-releasing contraceptive implant in women with sickle cell anemia during twelve months.

NCT ID: NCT02592434 Completed - Clinical trials for Juvenile Idiopathic Arthritis

Efficacy Study Of Tofacitinib In Pediatric JIA Population

Start date: June 10, 2016
Phase: Phase 3
Study type: Interventional

Evaluate efficacy, safety and tolerability of tofacitinib in pediatric JIA patients.

NCT ID: NCT02589301 Completed - Healthy Clinical Trials

Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations

Start date: November 2015
Phase: Phase 1
Study type: Interventional

This study will evaluate the pharmacokinetics (relative bioavailability) and pharmacodynamics, after single subcutaneous application, in healthy volunteers of both sexes, between pegfilgrastim formulation, produced by Eurofarma Laboratorios S/A and Neulastim® (reference formulation), marketed by Produtos Roche Químicos e Farmacêuticos S/A. In addition to that, a pharmacodynamics comparison will be performed, through change in absolute neutrophil count in leukogram performed in the same time of pharmacokinetics analysis collection and through CD34+ cell count in peripheral blood at timepoints 0:00, 96:00 and 384:00 hours.

NCT ID: NCT02588911 Completed - Clinical trials for Venous Insufficiency

Radiofrequency Ablation vs Conventional Surgery for Superficial Venous Insufficiency

Start date: November 2013
Phase: N/A
Study type: Interventional

The current study was a double blind randomised controlled trial that compared radiofrequency ablation (RFA) versus conventional surgery (CS) in patients who served as their own controls and who had intact great saphenous veins (GSVs).

NCT ID: NCT02588768 Completed - Performance Clinical Trials

Photobiomodulation Therapy in a Field Test With High-level Rugby Players

Start date: February 2015
Phase: N/A
Study type: Interventional

Background/Aim: While growing evidence supports the use of photobiomodulation therapy (PBMT) for performance and recovery enhancement, there have only been laboratory-controlled studies. Therefore, the aim of this study was to analyze the effects of PBMT in performance and recovery of high-level rugby players during an anaerobic field test. Methods: It is a randomized, crossover, double-blinded, placebo-controlled trial. Twelve male high-level rugby athletes were recruited in this study. No intervention was performed before the Bangsbo Sprint Test (BST) at familiarization phase (week 1). At weeks 2 and 3, pre-exercise PBMT or placebo were randomly applied to each athlete. PBMT/placebo irradiation was performed at 17 sites of each lower limb, employing a cluster with 12 diodes (4 laser diodes of 905nm, 4 LED diodes of 875nm, and 4 LED diodes of 640nm, 30J per site - manufactured by Multi Radiance Medical™). Average time of sprints, best time of sprints, and fatigue index were obtained from BST. Blood lactate levels were assessed at baseline, and at 3, 10, 30 and 60 minutes after BST. Athletes' perceived fatigue was also assessed through a questionnaire.

NCT ID: NCT02586376 Completed - Clinical trials for Chronic Kidney Failure

Effects of the Low-level Laser Therapy (LLLT) on Muscle Strength (MS) of the Patients With Kidneys Failure (KF)

LLLTMSKF
Start date: October 2015
Phase: N/A
Study type: Interventional

The low-level laser therapy (LLLT) has been used in many inflammatory disorders. More recently the LLLT was associated with an improvement in the muscle strength and endurance. But, these effects were described only in health or athletic individuals. In this randomized and controlled clinical trails, the investigators will study the effects of LLLT on muscle strength of the patients with kidneys failure on long time hemodialysis treatment. Additionally, investigators will explore three different intensities up the muscle strength.

NCT ID: NCT02583880 Completed - Malnutrition Clinical Trials

Screening Day Latin America

Start date: October 2015
Phase: N/A
Study type: Observational

This is a survey which will be performed on a specific day (the "Screening Day") in Latin American ICUs. In eligible patients who receive enteral or parenteral nutrition a retrospective calculation of the "caloric deficit" will be performed. The caloric deficit is the difference between energy target of each patient and actually administered calories.

NCT ID: NCT02582892 Completed - Osteoporosis Clinical Trials

Systemic Vitamin D Supplementation in Dental Implants Patients

VitaminD
Start date: October 2012
Phase: Phase 4
Study type: Interventional

Vitamin D plays an essential role in calcium homeostasis and is critical for bone formation and remodeling.